Genetic variants in the inflammation pathway as predictors of recurrence and progression in non-muscle invasive bladder cancer treated with Bacillus Calmette-Guérin.

Oncotarget · 2017 · PMC5687645 · PMID 29179475

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Kaplan–Meier survival analysis also showed significant to borderline significant difference in progression free time by SNP rs7089861 genotype in the discovery and validation phases in patients who underwent BCG therapy (Figure 1 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.